1.
Layas G, Isreb M, Ghaderi N, et al. Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo. Am. J. Life Sci. Innov. 2025;4(1):27-35. doi:10.54536/ajlsi.v4i1.3268